NeuroMD Medical Technologies Develops At-Home Pain Relief Device

Chronic pain affects millions of Americans and limits daily activities such as work and mobility. Anthony Rumbello, CEO of NeuroMD Medical Technologies, said patients are seeking alternatives to pharmaceuticals but remain uncertain about product credibility.

Rumbello stated that the market contains many devices making unverified claims. He said NeuroMD Medical Technologies designed its device with clinical support and regulatory review in mind.

The device uses neuromuscular electrical stimulation technology that targets both motor nerves and sensory nerves. Rumbello said this dual approach addresses underlying muscular responses rather than a single pathway. Preset parameters include frequency measured in hertz, pulse duration, and duty cycle.

These settings determine waveform strength and depth of stimulation, allowing the device to reach deeper stabilizing muscles in areas such as the back.

Rumbello noted that the wellness device market has become saturated with unregulated products, creating consumer confusion. He said NeuroMD Medical Technologies has prioritized transparency in response. The company’s traditional users are individuals over age 45, but Rumbello reported growing interest among younger consumers concerned with prevention and performance.

He said today’s customers demand evidence and ask more detailed questions. Rumbello described the company’s goal as helping users move better, feel stronger, and regain confidence. He said pain relief is one outcome among several related to physical resilience.

This article is for informational purposes only and does not substitute for professional medical advice.